{"title":"恶性非霍奇金淋巴瘤的预后与治疗。","authors":"B Brockmann, K H Riessbeck","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Rarely low malignant Non-Hodgkin-lymphomas (NHL) can be attended curatively. An alternative to hitherto applied chemotherapy in advanced stages is the retarded therapeutic proceeding in the so-called \"indolent\" NHL. However, the optimal therapeutic regimen is unknown. High malignant NHL can be attended curatively to a high percentage. With protocols of therapy in 2. and 3. generation the total remission rate could be increased and the rate of relapses could be decreased compared with the CHOP-scheme. The application of radiotherapy is not defined sufficiently in high malignant NHL yet.</p>","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"30 2","pages":"101-6"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Prognosis and therapy of malignant non-Hodgkin's lymphoma].\",\"authors\":\"B Brockmann, K H Riessbeck\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Rarely low malignant Non-Hodgkin-lymphomas (NHL) can be attended curatively. An alternative to hitherto applied chemotherapy in advanced stages is the retarded therapeutic proceeding in the so-called \\\"indolent\\\" NHL. However, the optimal therapeutic regimen is unknown. High malignant NHL can be attended curatively to a high percentage. With protocols of therapy in 2. and 3. generation the total remission rate could be increased and the rate of relapses could be decreased compared with the CHOP-scheme. The application of radiotherapy is not defined sufficiently in high malignant NHL yet.</p>\",\"PeriodicalId\":76404,\"journal\":{\"name\":\"Radiobiologia, radiotherapia\",\"volume\":\"30 2\",\"pages\":\"101-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiobiologia, radiotherapia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiobiologia, radiotherapia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Prognosis and therapy of malignant non-Hodgkin's lymphoma].
Rarely low malignant Non-Hodgkin-lymphomas (NHL) can be attended curatively. An alternative to hitherto applied chemotherapy in advanced stages is the retarded therapeutic proceeding in the so-called "indolent" NHL. However, the optimal therapeutic regimen is unknown. High malignant NHL can be attended curatively to a high percentage. With protocols of therapy in 2. and 3. generation the total remission rate could be increased and the rate of relapses could be decreased compared with the CHOP-scheme. The application of radiotherapy is not defined sufficiently in high malignant NHL yet.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
